Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

Clinical trial NCT04582591 · UNKNOWN

Trial details

NCT number: NCT04582591
Sponsor: Zealand University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy

Start date: 2021-03-03
Primary completion: 2022-01-05
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.